Dyne Therapeutics(DYN)
$17.99+0.07 (+0.39%)
DYN
Dyne Therapeutics financials statements
$17.99
At close:+0.07 (+0.39%)
Want to see DYN full AI Analyst Report?
Dyne Therapeutics (DYN) Income Statement
489 Followers
Dyne Therapeutics Income Statement
Last quarter (Q3 2026), Dyne Therapeutics's total revenue was $0.00. In Q3, Dyne Therapeutics's net income was $-193.55M. See Dyne Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -2.05M | $ -2.24M | $ -2.46M | $ 0.00 | $ 0.00 | |
| $ 466.13M | $ 341.64M | $ 239.70M | $ 170.96M | $ 150.03M | |
| Depreciation and Amortization | $ 2.05M | $ 1.67M | $ 1.67M | $ 1.68M | $ 1.09M |
| $ -437.97M | $ -315.75M | $ -234.26M | $ -163.50M | $ -148.20M | |
| $ -468.18M | $ -343.89M | $ -242.16M | $ -170.96M | $ -150.03M | |
| $ 21.97M | $ 26.47M | $ 6.22M | $ 2.86M | $ 734.00K | |
| $ -446.21M | $ -317.42M | $ -235.94M | $ -168.10M | $ -149.29M | |
| $ -446.21M | $ -317.42M | $ -235.94M | $ -168.10M | $ -149.29M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.47 | $ -3.37 | $ -3.95 | $ -3.23 | $ -2.93 |
| Diluted EPS | $ -3.47 | $ -3.37 | $ -3.95 | $ -3.23 | $ -2.93 |
| Weighted Average Shares Outstanding | 128.44M | 94.14M | 59.68M | 51.98M | 50.90M |
| Weighted Average Shares Outstanding (Diluted) | 128.44M | 94.14M | 59.68M | 51.98M | 50.90M |
Currency in USD
